Demands of disease drive vaccine scienceProducers aim much R&D at targets such as Ebola and HIV for which no vaccine existsShandong vaccine scandal damages confidence in China health systemChinese black market case shines light on poor regulationZika vaccine researchers seek to ‘fight fire with fire’Plans include using one virus to attack anotherAmid vaccine debate, Italy faces return of eradicable diseasesMoves to widen vaccination coverage meet strong political oppositionScience looks to nucleic acids to create right genetic vaccine recipeProponents say vaccines made of RNA and DNA will prove safer and cheaperTrump era strengthens the vaccine doubters’ resolveMedical community worries as a powerful new voice amplifies support for the ‘vaccine hesitant’More from this Special ReportPartnership of nations set to combat pandemic health threatsInternational team of specialists takes fight to emerging lethal infections that as yet have no name‘Holy grail’ of universal cancer cure remains a distant prospectSuccessful trials and wide-ranging approaches continue to stir hopes of new means of tackling the disease
Demands of disease drive vaccine scienceProducers aim much R&D at targets such as Ebola and HIV for which no vaccine existsShandong vaccine scandal damages confidence in China health systemChinese black market case shines light on poor regulationZika vaccine researchers seek to ‘fight fire with fire’Plans include using one virus to attack anotherAmid vaccine debate, Italy faces return of eradicable diseasesMoves to widen vaccination coverage meet strong political oppositionScience looks to nucleic acids to create right genetic vaccine recipeProponents say vaccines made of RNA and DNA will prove safer and cheaperTrump era strengthens the vaccine doubters’ resolveMedical community worries as a powerful new voice amplifies support for the ‘vaccine hesitant’More from this Special ReportPartnership of nations set to combat pandemic health threatsInternational team of specialists takes fight to emerging lethal infections that as yet have no name‘Holy grail’ of universal cancer cure remains a distant prospectSuccessful trials and wide-ranging approaches continue to stir hopes of new means of tackling the disease
